$EDSA
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Healthcare
Sector
Biotechnology
Industry
Pardeep Nijhawan
CEO
16
Employees
$7.35
Current Price
$8.50M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 1 | 1 | $6,598.90 | 1,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 9 | $233,054.05 | 86,571 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 9 | $233,054.05 | 86,571 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 9 | $233,054.05 | 86,571 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Brooks Michael J President | Purchase | 2,000 | $1.57 | $3,140.00 | View Details |
| Mar 10, 2026 | Nijhawan Pardeep Director | Purchase | 1,000 | $6.60 | $6,598.90 | View Details |
| Mar 5, 2026 | Nijhawan Pardeep Director | Purchase | 10,000 | $3.90 | $39,000.00 | View Details |
| Mar 4, 2026 | Nijhawan Pardeep Director | Purchase | 10,000 | $4.26 | $42,560.00 | View Details |
| Mar 3, 2026 | Nijhawan Pardeep Director | Purchase | 10,000 | $3.63 | $36,300.00 | View Details |
| Mar 2, 2026 | Nijhawan Pardeep Director | Purchase | 2,000 | $2.00 | $4,000.00 | View Details |
| Mar 2, 2026 | Nijhawan Pardeep Director | Purchase | 1,000 | $2.28 | $2,279.60 | View Details |
| Feb 26, 2026 | Nijhawan Pardeep Director | Purchase | 20,571 | $1.58 | $32,479.55 | View Details |
| Feb 27, 2026 | Nijhawan Pardeep Director | Purchase | 30,000 | $2.22 | $66,696.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.28
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history